The Wells Investment
VC Fund
The Wells Investment is a VC fund focused on Artificial Intelligence and Health Care. The Wells Investment
- Total investments:
- 10
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries The Wells Investment invests in
Stages The Wells Investment invests in
Countries The Wells Investment invests in
Round sizes
Round size
- Series A
- $2.2M–$12M
- Series B
- $10M–$17M
Investment Focus
Industry
- Artificial Intelligence 3 (30%)
- Health Care 2 (20%)
- Biotechnology 2 (20%)
- Apps 1 (10%)
- FinTech 1 (10%)
Stage
- Series A 6 (60%)
- Series B 3 (30%)
- Series C 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oasis Business
|
Oasis Business is an information services company that provides AI solutions to the finance, construction, and distribution industries. | $3.8M / Series A / May 24, 2023 | |
ADDD
|
Addd's AI technology analyses outdoor video data to determine the gender and age of the area's floating population. Furthermore, the effect can be measured and quantified by establishing whether they were aware of the advertisement and whether they viewed it with interest. This technology is also applicable to moving media and can be usedto determine the properties of moving things. It analyses video in real-time via the vision sensor camera and sends data solely to the client via a specified IP address to ensure privacy and safety. | Series A / May 05, 2023 | |
GenKOre
|
GenKOre operates as a biotech company, specializing in genetic scissors. | $12.3M / Series A / Nov 07, 2022 | |
Deargen
|
Deargen provides AI-based genome analysis service. | $16.6M / Series B / Feb 24, 2022 | |
Sendy
|
sendy Korea is a cloud-based logistics platform that provides on-demand freight transportation services. | $3.9M / Series A / Nov 23, 2021 | |
CodeBrick
|
Codebrick is a technical co-founder for local SEA entrepreneurs. Codebrick is a technical co-founder for local SEA entrepreneurs. Codebrick operates as an equity partner -this aligns the interests of the technical co-founder with those of the entrepreneur. | $12M / Series B / Jun 28, 2021 | |
3billion
|
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $13M / Series C / Mar 26, 2021 | |
|
3billion
|
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $10M / Series B / Oct 04, 2019 | |
|
3billion
|
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $2.2M / Series A / Jul 11, 2018 | |
MOIN
|
MOIN is a specialized cross-border payment network provider that offers remittance and payment services to both individuals and corporates | $2.3M / Series A / Jan 02, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does The Wells Investment invest in?
The Wells Investment invests primarily in Artificial Intelligence, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is The Wells Investment's check size?
The Wells Investment typically joins rounds of $2.2M–$12M at Series A and $10M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds The Wells Investment participates in.
When did The Wells Investment last invest?
The most recent investment recorded for The Wells Investment closed in May 2023. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
